Ochsner Health is the leading nonprofit healthcare provider in the Gulf South. Ochsner inspires healthier lives and stronger communities through our mission to serve, heal, lead, educate and innovate.
As the first hospital in the area to offer this minimally invasive solution, Ochsner Lafayette General is leading the way in improving lung cancer diagnosis and patient care.
Read More50,000 minimally invasive robot-assisted surgeries have been performed across the Ochsner Health system, reflecting Ochsner’s dedication to innovation and providing patients with the most advanced healthcare options.
Read MoreStroke remains a global health challenge, ranking second in worldwide mortality and fifth in U.S. deaths. In response, researchers at Ochsner Health, led by Hernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence.
Read MoreUnlike other programs that simply monitor health conditions, Ochsner Digital Medicine offers comprehensive care, including adjusting medications to find the right treatment, health coaching, and managing conditions with specialized clinicians.
Read MoreOchsner Health, a leading nonprofit healthcare provider in the Gulf South, has been selected by the Global Parkinson’s Genetics Program (GP2) as one of six new study sites for the Black and African American Connections to Parkinson’s Disease study.
Read MoreThis prestigious validation recognizes the innovative use of technology to drive better patient care across all 46 hospitals and 390 clinics within the Ochsner system throughout the Gulf Coast region.
Read MoreWith the addition of weight management, Digital Medicine is meeting members across the entire cardiometabolic health spectrum for more personalized care.
Read MoreUtilizing remote patient management (RPM), Ochsner Digital Medicine and AmeriHealth Caritas Louisiana will work together to help members with certain chronic conditions better manage their health and improve their quality of life.
Read MoreThe collaboration has seen notable results for patient satisfaction and provider adoption, with DeepScribe AI to be rolled out across the 46-hospital system.
Read MoreThe Ion robot advancements are critical for treating lung cancer, since early detection is key to achieving the best outcome. Every six weeks of delayed treatment lowers a lung cancer patient’s five-year survival rate by 14%.
Read More